Authors:
NEIDHART W
BREU V
BURRI K
CLOZEL M
HIRTH G
KLINKHAMMER U
GILLER T
RAMUZ H
Citation: W. Neidhart et al., DISCOVERY OF RO-48-5695 - A POTENT MIXED ENDOTHELIN RECEPTOR ANTAGONIST OPTIMIZED FROM BOSENTAN, Bioorganic & medicinal chemistry letters, 7(17), 1997, pp. 2223-2228
Authors:
ROUX S
BREU V
GILLER T
NEIDHART W
RAMUZ H
COASSOLO P
CLOZEL JP
CLOZEL M
Citation: S. Roux et al., RO-61-1790, A NEW HYDROSOLUBLE ENDOTHELIN ANTAGONIST - GENERAL PHARMACOLOGY AND EFFECTS ON EXPERIMENTAL CEREBRAL VASOSPASM, The Journal of pharmacology and experimental therapeutics, 283(3), 1997, pp. 1110-1118
Authors:
CRAMERI Y
FORICHER J
HENGARTNER U
JENNY CJ
KIENZLE F
RAMUZ H
SCALONE M
SCHLAGETER M
SCHMID R
WANG SN
Citation: Y. Crameri et al., ASYMMETRIC HYDROGENATION VS RESOLUTION IN THE SYNTHESIS OF POSICOR(R), A NEW-TYPE OF CALCIUM-ANTAGONIST, Chimia, 51(6), 1997, pp. 303-305
Citation: G. Hopfgartner et al., FRAGMENTATION OF BOSENTAN(R) (RO-47-0203) IN IONSPRAY MASS-SPECTROMETRY AFTER COLLISION-INDUCED DISSOCIATION AT LOW-ENERGY - A CASE OF RADICAL FRAGMENTATION OF AN EVEN-ELECTRON ION, Journal of mass spectrometry., 31(1), 1996, pp. 69-76
Authors:
BREU V
CLOZEL M
BURRI K
HIRTH G
NEIDHART W
RAMUZ H
Citation: V. Breu et al., IN-VITRO CHARACTERIZATION OF RO-46-8443, THE FIRST NONPEPTIDE ANTAGONIST SELECTIVE FOR THE ENDOTHELIN ET(B) RECEPTOR, FEBS letters, 383(1-2), 1996, pp. 37-41
Authors:
NEIDHART W
BREN V
BUR D
BURRI K
CLOZEL M
HIRTH G
MULLER M
WESSEL HP
RAMUZ H
Citation: W. Neidhart et al., THE DISCOVERY OF NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONISTS - PROGRESSION TOWARDS BOSENTAN, Chimia, 50(11), 1996, pp. 519-524
Authors:
ELIASON JF
SAWADA R
TSUKAGUCHI T
KOBAYASHI K
ICHIHARA S
KONISHI C
HORII I
KURUMA I
RAMUZ H
Citation: Jf. Eliason et al., THE DITHIANE RO-44-5912 ENHANCES VINBLASTINE SENSITIVITY OF DRUG-RESISTANT AND PARENTAL KB LINES IN-VIVO, European journal of cancer, 31A(13-14), 1995, pp. 2354-2361
Authors:
BREU V
HASHIDO K
BROGER C
MIYAMOTO C
FURUICHI Y
HAYES A
KALINA B
LOFFLER BM
RAMUZ H
CLOZEL M
Citation: V. Breu et al., SEPARABLE BINDING-SITES FOR THE NATURAL AGONIST ENDOTHELIN-1 AND THE NONPEPTIDE ANTAGONIST BOSENTAN ON HUMAN ENDOTHELIN-A RECEPTORS, European journal of biochemistry, 231(1), 1995, pp. 266-270
Authors:
ELIASON JF
RAMUZ H
YOSHIKUBO T
ISHIKAWA T
YAMAMOTO T
TSURUO T
Citation: Jf. Eliason et al., NOVEL DITHIANE ANALOGS OF TIAPAMIL WITH HIGH-ACTIVITY TO OVERCOME MULTIDRUG-RESISTANCE IN-VITRO, Biochemical pharmacology, 50(2), 1995, pp. 187-196
Authors:
CLOZEL M
BREU V
GRAY GA
KALINA B
LOFFLER BM
BURRI K
CASSAL JM
HIRTH G
MULLER M
NEIDHART W
RAMUZ H
Citation: M. Clozel et al., PHARMACOLOGICAL CHARACTERIZATION OF BOSENTAN, A NEW POTENT ORALLY-ACTIVE NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONIST, The Journal of pharmacology and experimental therapeutics, 270(1), 1994, pp. 228-235
Authors:
CLOZEL M
BREU V
BURRI K
CASSAL JM
FISCHLI W
GRAY GA
HIRTH G
LOFFLER BM
MULLER M
NEIDHART W
RAMUZ H
Citation: M. Clozel et al., PATHOPHYSIOLOGICAL ROLE OF ENDOTHELIN REVEALED BY THE 1ST ORALLY-ACTIVE ENDOTHELIN RECEPTOR ANTAGONIST, Nature, 365(6448), 1993, pp. 759-761